{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:37:06Z","timestamp":1740119826344,"version":"3.37.3"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002635","name":"Inha University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.transproceed.2024.01.031","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:26:59Z","timestamp":1708576019000},"page":"726-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction\u2013Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation"],"prefix":"10.1016","volume":"56","author":[{"given":"Jin Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeryong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kipyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoung Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-2510","authenticated-orcid":false,"given":"Seun Deuk","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.01.031_bib0001","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States","volume":"93","author":"Montgomery","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2017.00234","article-title":"ABO-incompatible kidney transplantation","volume":"8","author":"Morath","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0003","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2215\/CJN.04410512","article-title":"Common infections in kidney transplant recipients","volume":"7","author":"Karuthu","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"issue":"Suppl 7","key":"10.1016\/j.transproceed.2024.01.031_bib0005","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1093\/clinids\/12.Supplement_7.S754","article-title":"Impact of cytomegalovirus infection on organ transplant recipients","volume":"12","author":"Rubin","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/00003495-200565060-00012","article-title":"Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients","volume":"65","author":"Cvetkovi\u0107","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0007","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/tid.12247","article-title":"Current characteristics and outcome of cytomegalovirus infections after kidney transplantation","volume":"16","author":"Helanter\u00e4","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0008","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1600-6143.2006.01403.x","article-title":"BK virus infection in transplant recipients: an overview and update","volume":"6","author":"Randhawa","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2024.01.031_bib0009","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.2215\/CJN.00920207","article-title":"BK virus nephropathy and kidney transplantation","volume":"2","author":"Bohl","year":"2007","journal-title":"Clinical J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOT.0000000000000101","article-title":"BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions","volume":"19","author":"Pham","year":"2014","journal-title":"Cur Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0012","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0013","doi-asserted-by":"crossref","first-page":"e13300","DOI":"10.1111\/tid.13300","article-title":"Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients","volume":"22","author":"Moon","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2024.01.031_bib0014","doi-asserted-by":"crossref","first-page":"e14241","DOI":"10.1111\/petr.14241","article-title":"Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplant","volume":"26","author":"Mohammad","year":"2022","journal-title":"Pediatr Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:37:03Z","timestamp":1729226223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0041134524000289"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.01.031","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction\u2013Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}